2025-05-20
Wall Street Journal
29 related
Regeneron Pharmaceuticals says it will acquire 23andMe's assets, including its Personal Genome Service, for $256M, set to close in Q3, in the bankruptcy auction
But What Happens to Your Data? David Braue / Information Age : Biotech buys bankrupt DNA data firm 23andMe for $400m Naomi Li Gan / Tech in Asia : Pharma giant Regeneron to buy genetics firm 23andMe f...
Loading articles...